Establishment Labs Holdings Inc. (NASDAQ:ESTA) Q4 2023 Earnings Call Transcript February 28, 2024 Establishment Labs Holdings Inc. beats earnings expectations. Reported EPS is $-0.79, expectations were $-0.95. ESTA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. Welcome to […]
NEW YORK, October 16, 2023 Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Motiva Flora® SmoothSilk® Tissue Expander.
September is traditionally known to be a challenging month for the stock market, with historical data showing it is usually the worst month of the year for stocks. However, when considering year-to-date activity, J.P. Morgan’s Global Investment Strategist, Madison Faller, points out that this may not be the case this year. “A closer look shows that in the 10 times since 1950 that the S&P 500 has been up at least 10% year-to-date and it’s been down in August (just like this year), September has b